The Mixed Hepatocellular-Cholangiocarcinoma Confirmed by Liver and Neck Node Biopsy
Published Online: Sep 30, 2009
Abstract
Mixed hepatocellular-cholangiocarcinoma accounts for about 1% of all hepatocellular carcinoma. In many cases, mixed hepatocellular-cholangiocarcinoma has been misdiagnosed as hepatocellular carcinoma or cholangiocarcinoma because of the indistinctive clinical course and radiologic findings. The clinical course and the pathologic characters are not known well, but it resembles the characteristics of hepatocellularcarcinoma rather than cholangiocarcinoma. So mixed hepatocellular-cholangiocarcinoma was classified as a kind of hepatocellular carcinoma. But the growth and dissemination rate is faster than that of hepatocellular carcinoma and the prognosis more poor. So the exact diagnosis is important. Authors experienced a patient who has the mixed hepatocellular-cholangiocarcinoma diagnosed by liver and neck node biopsy in patient who complain-ed abdominal discomfort and palpable mass, so we report the case.
Metrics
QR Code of this Article:
Related Articles
Cellular Localization of RANKL and RANK Production in Giant Cell Tumors of Bone and Tendon Sheath by Immunohistochemistry
Ewha Med J 2010;33(1):23-28.
Expression of CD44 according to Clinicopathologic Characteristics of Gastric Cancer
Ewha Med J 2018;41(3):63-74.
Expression of Multidrug Resistance Gene Product in Laryngeal Squamous Cell Carcinoma
Ewha Med J 1996;19(1):125-131.
The Immunohistochemical and Electron Microscopic Observation of Metastatic Small Cell Lung Cancer of Liver
Ewha Med J 2009;32(1):3-8.
Histological Classification of Endoscopically Diagnosed Polypoid Lesion of Stomach
Ewha Med J 1998;21(3):195-201.